4.5 Article

Regulation of anti-tumorigenic pathways by the combinatory treatment of calcitriol and TGF-β in PC-3 and DU145 cells

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jsbmb.2021.105831

关键词

Calcitriol; TGF-?; IGFBP3; CDKN1A; CCNA1; Prostate cancer cells; Microarray

资金

  1. CONACyT, Mexico [282770]

向作者/读者索取更多资源

Calcitriol and TGF-β play important roles in biological pathways such as cell proliferation, differentiation, and invasion, with their cellular effects depending on genetic targets and cell types. Combinatory treatment of calcitriol and TGF-β in human prostate cancer cell lines affects the expression of a set of genes and pathways, leading to inhibition of cell growth and improvement in cancer signaling.
Calcitriol and transforming growth factors beta (TGF-?) are involved in several biological pathways such as cell proliferation, differentiation, migration and invasion. Their cellular effects could be similar or opposite depending on the genetic target, cell type and context. Despite the reported association of calcitriol deficiency and disruption of the TGF-? pathway in prostate cancer and the well-known independent effects of calcitriol and TGF-?s on cancer cells, there is limited information regarding the cellular effects of calcitriol and TGF-? in combination. In this study, we in vitro analyze the combinatory effects of calcitriol and TGF-? on cell growth and apoptosis using PC-3 and DU145 human prostate cancer cell lines. Using high-throughput microarray profiling of PC-3 cells upon independent and combinatory treatments, we identified distinct transcriptional landscapes of each intervention, with a higher effect established by the combinatorial treatment, following by TGF-?1 and later by calcitriol. A set of genes and enriched pathways converge among the treatments, mainly between the combinatory scheme and TGF-?1, but the majority were treatment-specific. Of note, CYP24A1, IGFBP3, CDKN1A, NOX4 and UBE2D3 were significantly up-regulated upon the combinatorial treatment whereas CCNA1, members of the CT45A and APOBEC3 family were down-regulated. By public RNA signatures, we were able to confirm the regulation by the co-treatment over cell proliferation and cell cycle. We finally investigated the possible clinical impact of genes modulated by the combinatorial treatment using benchmark prostate cancer data. This comprehensive analysis reveals that the combinatory treatment impairs cell growth without affecting apoptosis and their combinatory actions might synergize and improved their individual effects to reprogram prostate cancer signaling.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据